Vision and brain study for macular degeneration
Part of Eyes & vision clinical trials.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with age-related macular degeneration (AMD).
- Your vision is not too poor—better than 20/100 in the eye being studied.
- You do not have any other eye diseases besides AMD.
- You do not have any uncontrolled health problems that could affect the study results, like unstable diabetes or high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
This study observes how dry age-related macular degeneration (AMD) progresses over time. It helps doctors learn more about the disease, which may lead to better treatments in the future.
This study tests a new treatment to improve vision in people with advanced age-related macular degeneration (AMD). If you have significant vision loss from AMD, this might help you see better.
This study uses special eye scans and tests to look for blood vessel problems that may be linked to dry age-related macular degeneration (AMD). It might help find new ways to treat the condition.
Hear when a new Neovascular (Wet) Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.